The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections

NCT05615805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2023-04-25

No results posted yet for this study

Summary

This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.

Conditions

  • Intravitreal Injection
  • Ocular Rinse
  • Age-Related Macular Degeneration
  • Diabetic Macular Edema
  • Cystoid Macular Edema

Interventions

OTHER

OSDI questionnaire

Ocular Surface Disease Index

OTHER

SPEEDII questionnaire

Standardized Patient Evaluation of Eye Dryness II questionnaire

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-07-30
Completion
2021-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05615805 on ClinicalTrials.gov